Zoetis

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Zoetis 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ZTS

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. It operates through the United States and International geographical segments. 

CEO
Kristin C. Peck
CEOKristin C. Peck
Employees
14,500
Employees14,500
Headquarters
Parsippany, New Jersey
HeadquartersParsippany, New Jersey
Founded
1952
Founded1952
Employees
14,500
Employees14,500

ZTS Key Statistics

Market cap
28.79B
Market cap28.79B
Price-Earnings ratio
11.37
Price-Earnings ratio11.37
Dividend yield
3.02%
Dividend yield3.02%
Average volume
4.63M
Average volume4.63M
High today
$70.10
High today$70.10
Low today
$68.78
Low today$68.78
Open price
$69.11
Open price$69.11
Volume
5.25M
Volume5.25M
52 Week high
$148.79
52 Week high$148.79
52 Week low
$68.78
52 Week low$68.78

Stock Snapshot

With a market cap of 28.79B, Zoetis(ZTS) trades at $69.21. The stock has a price-to-earnings ratio of 11.37 and currently yields dividends of 3.02%.

During the trading session on 2026-10-02, Zoetis(ZTS) shares reached a daily high of $70.10 and a low of $68.78. At a current price of $69.21, the stock is +0.6% higher than the low and still -1.3% under the high.

Trading volume for Zoetis(ZTS) stock has reached 5.25M, versus its average volume of 4.63M.

The stock's 52-week range extends from a low of $68.78 to a high of $148.79.

The stock's 52-week range extends from a low of $68.78 to a high of $148.79.

ZTS News

MarketWatch 24h
Zoetis Inc. stock underperforms Thursday when compared to competitors - MarketWatch

...

Zoetis Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Simply Wall St 1d
Zoetis Could Be 25% Undervalued As Investors Question Growth

Zoetis (ZTS) has drawn investor attention after a steep share price slide this year, with the stock down sharply year to date as well as over the past month and...

Zoetis Could Be 25% Undervalued As Investors Question Growth

Analyst ratings

58%

of 19 ratings
Buy
42.1%
Hold
57.9%
Sell
0%

People also own

Based on the portfolios of people who own ZTS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.